FindTrial
Sign In

Use of bupivacaine and hydrocortisone during surgery to reduce pain after laparoscopic cholecystectomy

Intraperitoneal instillation of Bupivacaine & Hydrocortisone for postoperative analgesia in laparoscopic cholecystectomy - a prospective observational study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/03/018290
Enrollment
60
Registered
2019-03-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K819- Cholecystitis, unspecified

Interventions

Control Intervention1: Bupivacaine: intraperitoneal instillation of 25 cc 0.125% Bupivacaine alone Control Intervention2: Bupivacaine and Hydrocortisone: intraperitoneal instillation of 25 cc 0.125% B

Sponsors

Government Medical College Miraj
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA Grade I and II

Exclusion criteria

Exclusion criteria: 1. ASA grading III and above. 2. Allergy to local anesthetics 3. Patients with major Cardiac, Respiratory , Renal disease and obesity. 4. Surgery lasting more than 90 minutes.

Design outcomes

Primary

MeasureTime frame
intensity of pain post operativelyTimepoint: intensity of pain post operatively—

Secondary

MeasureTime frame
any complications like urinary retention, transient neurological symptomsTimepoint: 6 hours after surgery 10 hours after surgery 10th day—

Countries

India

Contacts

Public ContactDr Rajabhau Kshirsagar

Government Medical College, Miraj

dr.pradnyabhalerao@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026